`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE DISTRICT OF DELAWARE
`
`AMARIN PHARMA, INC., AMARIN
`PHARMACEUTICALS IRELAND
`LIMITED, MOCHIDA
`PHARMACEUTICAL CO., LTD.,
`
`Plaintiffs,
`
`v.
`
`HIKMA PHARMACEUTICALS USA INC.,
`HIKMA PHARMACEUTICALS PLC, AND
`HEALTH NET, LLC,
`
`Defendants.
`
`C.A. No. 20-1630-RGA- JLH
`
`JOINT CLAIM CONSTRUCTION CHART
`
`Pursuant to Paragraph 10 of the Scheduling Order (D.I. 50), Plaintiffs Amarin Pharma,
`
`Inc., Amarin Pharmaceuticals Ireland Limited, and Mochida Pharmaceutical Co., Ltd.,
`
`(collectively, “Amarin” or “Plaintiffs”) and Defendants Hikma Pharmaceuticals USA Inc.,
`
`Hikma Pharmaceuticals PLC (“Hikma”) and Health Net, LLC (“Health Net”) (collectively,
`
`“Defendants”) hereby submit this Joint Claim Construction Chart identifying for the Court the
`
`claim terms of U.S. Patent No. 10,568,861 (“the ’861 patent”), U.S. Patent No. 8,642,077 (“the
`
`’077 patent”), and U.S. Patent No. 9,700,537 (“the ’537 patent”) for which the parties have a
`
`dispute, together with the parties’ proposed constructions of the disputed claim language and
`
`citations to the supporting intrinsic evidence. Plaintiffs reserve the right to rely on intrinsic
`
`evidence identified by Defendants, and Defendants reserve the right to rely on intrinsic evidence
`
`identified by Plaintiffs.
`
`1
`
`Hikma Pharmaceuticals
`
`IPR2022-00215
`
`Ex. 1046, p. 1 of 5
`
`
`
`Case 1:20-cv-01630-RGA-JLH Document 94 Filed 11/15/21 Page 2 of 5 PageID #: 1490
`
`Hikma Pharmaceuticals
`
`IPR2022-00215
`
`Ex. 1046, p. 2 of 5
`
`
`
`Case 1:20-cv-01630-RGA-JLH Document 94 Filed 11/15/21 Page 3 of 5 PageID #: 1491
`
`Hikma Pharmaceuticals
`
`IPR2022-00215
`
`Ex. 1046, p. 3 of 5
`
`
`
`Case 1:20-cv-01630-RGA-JLH Document 94 Filed 11/15/21 Page 4 of 5 PageID #: 1492
`
`Dated: November 15, 2021
`
`
`FISH & RICHARDSON P.C.
`
`
`
`By: /s/ Jeremy D. Anderson
`Jeremy D. Anderson (No. 4515)
`222 Delaware Ave, 17th Floor
`Wilmington, DE 19801
`302-652-5070
`janderson@fr.com
`
`Elizabeth M. Flanagan (No. 5891)
`Michael Kane
`Deanna J. Reichel
`FISH & RICHARDSON P.C.
`60 South Sixth Street, #3200
`Minneapolis, MN 55402
`(612) 335-5070
`Emails: eflanagan@fr.com, kane@fr.com
`reichel@fr.com
`
`Jonathan E. Singer
`FISH & RICHARDSON P.C.
`12860 El Camino Real, Suite 400
`San Diego, CA 92130
`(858) 678-5070
`singer@fr.com
`
`COUNSEL FOR PLAINTIFFS
`AMARIN PHARMA, INC., AMARIN
`PHARMACEUTICALS IRELAND LIMITED,
`AND MOCHIDA PHARMACEUTICAL CO.,
`LTD.
`
`
`
`
`
`
`
`
`
`PHILLIPS, MCLAUGHLIN & HALL, P.A.
`
`By: /s/ David A. Bilson
`John C. Phillips, Jr. (No. 110)
`David A. Bilson (No. 4986)
`1200 N. Broom St.
`Wilmington, DE 19806
`302-655-4200
`jcp@pmhdelaw.com
`dab@pmhdelaw.com
`
`Don J. Mizerk
`HUSCH BLACKWELL LLP
`120 South Riverside Plaza, Suite 2200
`Chicago, IL 60606
`(312) 655-1500
`
`Dustin L. Taylor
`HUSCH BLACKWELL LLP
`1801 Wewatta Street, Suite 1000
`Denver, CO 80202
`(303) 749-7200
`
`COUNSEL FOR DEFENDANT
`HEALTH NET, LLC
`
`4
`
`Hikma Pharmaceuticals
`
`IPR2022-00215
`
`Ex. 1046, p. 4 of 5
`
`
`
`Case 1:20-cv-01630-RGA-JLH Document 94 Filed 11/15/21 Page 5 of 5 PageID #: 1493
`
`
`
`
`
`HEYMAN ENERIO GATTUSO & HIRZEL LLP
`
`By: /s/ Dominick T. Gattuso
`Dominick T. Gattuso (No. 3630)
`300 Delaware Avenue, Suite 200
`Wilmington, DE 19801
`302-472-7300
`dgattuso@hegh.law
`
`
`
`Charles B. Klein
`Claire A. Fundakowski
`WINSTON & STRAWN LLP
`1901 L Street, N.W.
`Washington, DC 20036
`202-282-5000
`
`Eimeric Reig-Plessis
`WINSTON & STRAWN LLP
`101 California Street
`San Francisco, CA 94111
`415-591-6808
`
`Alison M. King
`WINSTON & STRAWN LLP
`35 W. Wacker Drive
`Chicago, IL 60601
`312-558-5600
`
`COUNSEL FOR DEFENDANTS
`HIKMA PHARMACEUTICALS USA INC. AND
`HIKMA PHARMACEUTICALS PLC
`
`5
`
`Hikma Pharmaceuticals
`
`IPR2022-00215
`
`Ex. 1046, p. 5 of 5
`
`